← All stocks

BMY vs NVO

Bristol-Myers Squibb Company Common Stock vs Novo Nordisk A/S Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BMY
Bristol-Myers Squibb Company Common Stock
Healthcare
62.62
127.91B
NVO
Novo Nordisk A/S Common Stock
Healthcare
39.80
191.03B
ACCE scores
BMY
NVO
Composite score
Out of 100
78
63
Growth
64
19
Value
88
91
Quality
83
96
Momentum
77
45
Valuation
BMY
NVO
Price
62.62
39.80
Market cap
127.91B
191.03B
Trailing P/E
13.79
10.73
Forward P/E
9.65
13.33
EV / EBITDA
9.68
9.06
Dividend yield
4.0%
4.2%
Profitability
BMY
NVO
ROE
46.6%
59.8%
Net margin
18.9%
35.4%
Debt / equity
2.44
0.67
Free cash flow
12.85B
28.99B
Growth
BMY
NVO
Revenue growth (YoY)
5.7%
2.1%
Earnings growth (YoY)
1.5%
-20.6%
Analyst target
66.71
46.80
See full analysis